Joerg Koglin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cardio-metabolic diseases - Merck com

Merck has a long history of making an impact in cardio-metabolic disorders, such as type 2 diabetes and cardiovascular disease.

Joerg koglinTexan jerry kreinerMerck research laboratoriesReducing disparitiesMerck researchJerry kreiner

FDA approves Merck lung disease drug acquired in $11B deal

BioPharma

Louise chenAcceleron pharmaJohnson opsumitIoana prestonJoerg koglinDrug administration onCantor fitzgeraldMerck coDrug administrationTufts medicineUnited therapeutic tyvasoNew jersey based

Pulmonary Arterial Hypertension Patients Receive Lifeline With FDA s Approval of New Drug

Pulmonary Arterial Hypertension Patients Receive Lifeline With FDA s Approval of New Drug
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesMarc humbertMatt granatoJoerg koglinPulmonary hypertension reference centerPulmonary hypertension associationDrug administrationMerck research laboratories

FDA signs off on Merck s potential blockbuster Winrevair for PAH

FDA signs off on Merck s potential blockbuster Winrevair for PAH
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesJoerg koglinBristol myers squibbInstitute for clinicalEconomic reviewUnited therapeutic adcircaChris schottMarket insights

FDA declines to approve gefapixant for chronic cough a second time

FDA declines to approve gefapixant for chronic cough a second time
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Joerg koglinAlexandra sasha todakMerck research laboratoriesAllergy drug advisory committee